Skip to main content
logo
ARS Pharmaceuticals, Inc. (SPRY)
NASDAQ: SPRY · Real-Time Price · USD
7.94
-0.29 (-3.52%)
At close: May 22, 2026, 4:00 PM EDT
8.07
+0.13 (1.64%)
After-hours: May 22, 2026, 7:19 PM EDT

ARS Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
7881,1571,033528801202
Market Cap Growth
-40.49%11.93%95.59%-34.07%296.19%-87.42%
Enterprise Value
758.691,008719.4300.03527.21227.13
Last Close Price
7.9411.6510.555.488.536.66
PE Ratio
--131.88---
PS Ratio
7.9713.7311.5917611.80608.9236.73
PB Ratio
12.8610.124.022.292.94-6.47
P/TBV Ratio
-8177.6510.054.212.261.25-6.15
P/FCF Ratio
--79.59---
P/OCF Ratio
--76.28---
EV/Sales Ratio
7.6611.968.0710001.00400.6141.25
EV/FCF Ratio
--55.40---
Debt / Equity Ratio
-1005.440.8400.000.000.20
Debt / FCF Ratio
--0.00---
Net Debt / Equity Ratio
1081.82-1.30-1.22-0.99-1.001.63
Net Debt / EBITDA Ratio
0.520.83104.523.387.722.65
Net Debt / FCF Ratio
0.590.87-24.183.846.802.90
Asset Turnover
0.320.250.310.000.010.02
Inventory Turnover
2.983.010.37---
Quick Ratio
4.636.9113.7595.5150.407.34
Current Ratio
4.947.2814.2696.9251.017.42
Return on Equity (ROE)
-346.83%-92.33%3.28%-21.59%-21.84%-9.47%
Return on Assets (ROA)
-65.80%-52.85%-1.02%-26.24%-20.72%-8.53%
Return on Invested Capital (ROIC)
-487.42%-607.93%-35.08%-2815.09%-17802.50%2882.07%
Return on Capital Employed (ROCE)
-76.90%-58.24%-1.10%-26.65%-21.57%-8.87%
Earnings Yield
--0.76%---
FCF Yield
--1.26%---
Buyback Yield / Dilution
-1.59%3.74%-7.54%-138.30%-38.39%-893.01%
Total Shareholder Return
-1.59%3.74%-7.54%-138.30%-38.39%-893.01%
Updated May 15, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q